Skip to content
drillr.ai
Sign up

600829.SH

HPGC Renmintongtai Pharmaceutical Corp.

SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN

CNY 8.56
−0.58%
Ask drillr

  • Oct 19, 2026, 12:51 UTC

    Renmin Tongtai reported revenue of 8.106 billion yuan and attributable net profit of 137 million yuan for the first three quarters of 2026, up 3.32% and 22.12% year over year, respectively.

    Source:

  • Oct 19, 2026, 12:51 UTC

    Renmin Tongtai reported third-quarter 2026 revenue of 2.698 billion yuan, up 0.06% year over year, and attributable net profit of 55.6187 million yuan, up 41.53%.

    Source: